Remeo Healthcare (Remeo), which forms part of The Active Care Group’s rehabilitation portfolio, has been shortlisted in the Respiratory Nursing category for the upcoming Nursing Times Awards 2020.

This year marks the 30th anniversary of the Nursing Times Awards, which recognises the dedication and hard work of the nursing profession across all sectors of UK healthcare.

Remeo are dedicated to improving the quality of life for those with complex respiratory ventilation requirements and delivering the highest standard of specialist patient care. They are also in their 5th year of its advanced high dependency respiratory nursing course, which has its own curriculum and has been accredited by the University of Surrey. This provides Remeo staff with the opportunity to progress to more senior nursing roles.

Oliver Harris, Montreux Capital Management (UK) CEO said, “Congratulations to the team at Remeo Healthcare. It is good to see their hard work and dedication to staff development being recognised by the industry. Best of luck.”

The full list of shortlisted finalists is available here.

The Awards ceremony will take place on Wednesday 14 October 2020 at the Grosvenor House Hotel, London.

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.